Oral Iron Therapy in Chronic Heart Failure Patients
NCT02698046 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2016-03-03
Summary
This study is design to evaluate the effectiveness of oral iron therapy in patients with heart failure and identify the central and peripheral mechanisms involved in the improvement of functional capacity after intervention. The investigation includes subjective and objective measures on exercise performance and heart function after intervention, and the tolerability of oral iron treatment.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Ferrous sulfate
200mg of ferrous sulfate three times a day for 4 months
- DIETARY_SUPPLEMENT
-
Placebo starch
200mg of placebo starch three times a day for 4 months
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
collaborator OTHER_GOV -
University of Sao Paulo
lead OTHER
Principal Investigators
-
Jaqueline RS Gentil, Master · University of Sao Paulo
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-10-31
Countries
- Brazil
Study Locations
More Related Trials
-
Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
NCT02392910 ·Status: COMPLETED ·Phase: PHASE4
-
EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
NCT00821717 ·Status: TERMINATED ·Phase: PHASE3
-
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
NCT03037931 ·Status: COMPLETED ·Phase: PHASE3
-
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
NCT03873584 ·Status: WITHDRAWN
-
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
NCT05793996 ·Status: RECRUITING ·Phase: PHASE4
-
Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants
NCT03359447 ·Status: UNKNOWN ·Phase: PHASE4
-
Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose
NCT01978028 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of 5-Aminolevulinic Acid on Iron Deficiency Anemia
NCT01380548 ·Status: COMPLETED ·Phase: NA
-
Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
NCT04253626 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease
NCT00384657 ·Status: WITHDRAWN ·Phase: PHASE3
-
IRONHEART: Intravenous Iron in Non-ischaemic Heart Failure
NCT06542822 ·Status: RECRUITING
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.
NCT02031289 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Iron Supplementation in Pulmonary Hypertension
NCT01446848 ·Status: COMPLETED ·Phase: NA
-
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Iron Oligosaccharide in CHF Patients
NCT00537186 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT01394562 ·Status: COMPLETED ·Phase: PHASE3
-
Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women
NCT01374776 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
NCT03074591 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
NCT00982007 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
NCT06427343 ·Status: RECRUITING ·Phase: PHASE4
-
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
NCT02541708 ·Status: UNKNOWN ·Phase: PHASE3
-
A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
NCT01114139 ·Status: COMPLETED ·Phase: PHASE3
-
Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation
NCT01785407 ·Status: COMPLETED ·Phase: NA
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA